Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02488499
Other study ID # 091/2010-03
Secondary ID
Status Completed
Phase N/A
First received June 24, 2015
Last updated February 6, 2017
Start date July 2010
Est. completion date December 2016

Study information

Verified date February 2017
Source Centre for Addiction and Mental Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the effectiveness of a clinic-adapted version of the Coping Power program compared to individualized child and family treatment for children with disruptive behaviour and their parents.


Description:

This project compares the short- and long-term effectiveness of a clinic-adapted manualized group treatment (i.e., Coping Power; CP) to individualized child and family treatment for children aged 9 - 12 with disruptive behaviour. Children and their parents who meet criteria and agree to participate in the project are randomly assigned to either the CP condition or the Individualized treatment condition. In the CP condition, children and caregivers are asked to participate in two separate but complimentary 15-session groups. Child groups target development of children's emotional and cognitive problem solving skills and caregiver groups facilitate cognitive and behavioural parenting skills. In the Individualized treatment condition children and caregivers are asked to participate in 15 one-hour individual and family treatment sessions tailored by the clinician to address the children and parent's presenting concerns. Measurement of behaviour and emotional functioning is done pre- post- and at 6-months following treatment.


Recruitment information / eligibility

Status Completed
Enrollment 172
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 9 Years to 12 Years
Eligibility Inclusion Criteria:

- Parents provide free and informed consent and children assent to participate in the research, complete measures, and participate in either Coping Power or individualized treatment.

- Parents report symptoms consistent with clinical diagnoses of Oppositional Defiant Disorder or Conduct Disorder on the Diagnostic Interview Schedule for Children - DSM IV or parents and/or teacher report at or above a T-score of 60 (93rd percentile; borderline clinically severe range) on the Externalizing Behavior composite scale on the Behavior Assessment for Children - 2nd edition.

- Parents or teachers report clinically severe impairment in social, family, peer or overall functioning demonstrated by scores in the clinical range on the parent or teacher completed Impairment Rating Scale.

- The child's cognitive functioning is at or above a standard score of 80 (Borderline Range) on the verbal and/or nonverbal scales on the Kaufman Brief Intelligence Task - 2.

Exclusion Criteria:

- Evidence of Autism Spectrum Disorder or Asperger's Disorder as reported by parent, teacher or physician referral (if available).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Coping Power
15 sessions of concurrent parent and child group treatment
Individualized Treatment
15 sessions of individualized child and parent treatment

Locations

Country Name City State
Canada Centre for Addiction and Mental Health Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Centre for Addiction and Mental Health Ontario Mental Health Foundation

Country where clinical trial is conducted

Canada, 

References & Publications (4)

Lochman JE, Powell N, Boxmeyer C, Andrade B, Stromeyer SL, Jimenez-Camargo LA. Adaptations to the coping power program's structure, delivery settings, and clinician training. Psychotherapy (Chic). 2012 Jun;49(2):135-42. doi: 10.1037/a0027165. Review. — View Citation

Lochman JE, Wells KC. The coping power program for preadolescent aggressive boys and their parents: outcome effects at the 1-year follow-up. J Consult Clin Psychol. 2004 Aug;72(4):571-8. — View Citation

Wells, K. C., Lochman, J. E., & Lenhart, L. A. (2008). Coping Power Parent Group Program: Facilitator Guide. New York: Oxford University Press.

Wells, K. C., Lochman, J. E., & Lenhart, L. A. (2008b). Coping Power: Facilitators Guide. New York: Oxford Press

Outcome

Type Measure Description Time frame Safety issue
Primary Conduct Problems scale score measured by the Strengths and Difficulties Questionnaire Change from Baseline Conduct Problems at 15-weeks and at 6 months
See also
  Status Clinical Trial Phase
Completed NCT00250354 - A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation Phase 3
Completed NCT03698240 - Mindfulness-based Program for Children With Disruptive Behavior Disorder N/A
Completed NCT01750996 - Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior Phase 1/Phase 2
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT02783560 - Behavioral Sleep Intervention in Children With Disruptive Behaviors N/A
Recruiting NCT02812537 - Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
Recruiting NCT04298437 - Addressing Depression and Positive Parenting Techniques (ADAPT) N/A
Completed NCT02704221 - Enhancing the Outcomes of a Behavioral Parent Training Intervention N/A
Completed NCT00236470 - A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders Phase 3
Recruiting NCT04113161 - Navigating Resource-Constrained Systems and Communities to Promote the Behavioral Health of Black Youth N/A
Enrolling by invitation NCT05425381 - Improving Social, Emotional, Behavioral, and Academic Functioning N/A
Completed NCT03796663 - Mindful Parenting and Parent Training Program Study N/A
Completed NCT00266552 - A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation Phase 3

External Links